Home/Filings/4/0001144204-18-029225
4//SEC Filing

MARSHBANKS TRACY 4

Accession 0001144204-18-029225

CIK 0001023024other

Filed

May 15, 8:00 PM ET

Accepted

May 16, 4:22 PM ET

Size

9.8 KB

Accession

0001144204-18-029225

Insider Transaction Report

Form 4
Period: 2018-05-14
Transactions
  • Sale

    Common Stock

    2018-05-16$62.40/sh25,706$1,604,054349,934 total(indirect: See Footnote)
  • Sale

    Common Stock

    2018-05-14$62.35/sh5,506$343,299382,664 total(indirect: See Footnote)
  • Sale

    Common Stock

    2018-05-15$62.05/sh7,024$435,839375,640 total(indirect: See Footnote)
Footnotes (4)
  • [F1]This transaction was executed in multiple trades at prices ranging from $62.00 to $62.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]This transaction was executed in multiple trades at prices ranging from $62.00 to $62.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]This transaction was executed in multiple trades at prices ranging from $62.00 to $62.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]Held by FA Private Equity Fund IV, L.P., FA Private Equity Fund IV GmbH & Co. Beteiligungs KG, The Productivity Fund IV Liquidating Trust, and The Productivity Fund IV Advisors Fund Liquidating Trust, which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).

Issuer

ANI PHARMACEUTICALS INC

CIK 0001023024

Entity typeother

Related Parties

1
  • filerCIK 0001579618

Filing Metadata

Form type
4
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:22 PM ET
Size
9.8 KB